Study ID | Objectives | Results observed | Overall inference assessed |
---|---|---|---|
Fries et al. [15] | Identify distinctive features of cocaine-exposed infants; evaluate if these findings may indicate fetal cocaine syndrome. | Distinctive phenotype in infants exposed to cocaine, including CL/P, neurological irritability, and other abnormalities. | Suggestive evidence for a diagnosis of fetal cocaine syndrome, needs further confirmation. |
Hume et al. [16] | Investigate the association between prenatal cocaine exposure and vascular disruption birth defects. | No clear association found between prenatal cocaine exposure and incidence of CL/P. | The putative association remained unresolved, and the risk is likely less than previously reported. |
Stafford et al. [17] | Examine the impact of prenatal cocaine exposure on infant eye health as well as the incidence of other craniofacial deformities. | No significant differences observed in congenital eye anomalies or other craniofacial deformities between exposed and non-exposed infants. | Prenatal cocaine exposure did not appear to affect infant eye health in this study group. |
Van Gelder et al. [18] | Assess the associations between periconceptional illicit drug use (cannabis, cocaine, stimulants) and birth defects. | Limited associations between periconceptional illicit drug use and selected birth defects; potential associations with anencephaly and CL/P. | Few positive associations found between periconceptional illicit drug use and birth defects. |